Evidence map›Paper›PMID 21093320›Full record

ArticleImmunity2010

MicroRNAs prevent the generation of autoreactive antibodies.

Laura Belver, Virginia G de Yébenes, Almudena R Ramiro

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 141 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Circulating miRNAs drive personalized medicine based on subgroup classification in myasthenia gravis patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  8. Post-transcriptional checkpoints in autoimmunity.Nature reviews. Rheumatology · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Laura BelverDNA Hypermutation and Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Virginia G de Yébenes
Almudena R Ramiro
Spanish National Cancer Research Centre · ES

Funding

European Research Council 207844
6 · The paper itself

Abstract

MicroRNAs have been shown to be critical for a number of aspects of immune system regulation and function. Here, we have examined the role of microRNAs in terminal B cell differentiation by analyzing Cd19-Cre(ki/+) Dicer1(fl/fl) mice. We found that in the absence of Dicer, the transitional and marginal zone (MZ) B cell compartments were overrepresented and follicular (FO) B cell generation was impaired. microRNA analysis revealed that miR185, a microRNA overexpressed in FO cells, dampened B cell receptor (BCR) signaling through Bruton tyrosine kinase downregulation. Dicer-deficient B cells had a skewed BCR repertoire with hallmarks of autoreactivity, which correlated with high titers of autoreactive antibodies in serum and autoimmune features in females. Together, our results reveal a crucial role for microRNAs in late B cell differentiation and in the establishment of B cell tolerance.

Indexed as

Lymphocyte ActivationAgammaglobulinaemia Tyrosine KinaseAnimalsAntigens, CD19AutoantibodiesB-LymphocytesCell DifferentiationDEAD-box RNA HelicasesDown-RegulationEndoribonucleasesFemaleImmune ToleranceMiceMice, KnockoutMicroRNAsProtein-Tyrosine KinasesAgammaglobulinaemia Tyrosine KinaseAntigens, CD19AutoantibodiesBtk protein, mouseDEAD-box RNA HelicasesDicer1 protein, mouseEndoribonucleasesMicroRNAsProtein-Tyrosine KinasesReceptors, Antigen, B-CellRibonuclease III

Identifiers

PMID21093320
PMCPMC3687137
OpenAlexW2106790562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.